Preclinical News and Research

RSS
Exposure to secondhand tobacco smoke increases the risk of developing dementia

Exposure to secondhand tobacco smoke increases the risk of developing dementia

Cancer Research Technology licenses therapeutic antibodies to Peptech

Cancer Research Technology licenses therapeutic antibodies to Peptech

Avicena files composition of matter patent application for treatment of Huntington's disease

Avicena files composition of matter patent application for treatment of Huntington's disease

Link found between bile duct obstruction and bile duct cancer

Link found between bile duct obstruction and bile duct cancer

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena files composition of matter patent application for treatment of Parkinson's disease

Gold nanoparticles for early detection of cancer

Gold nanoparticles for early detection of cancer

M. D. Anderson wins $8.3-million to research environmental causes of major diseases

M. D. Anderson wins $8.3-million to research environmental causes of major diseases

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Lexicon-Genentech reveals potential therapeutic targets

Lexicon-Genentech reveals potential therapeutic targets

ADVENTRX announces positive data from multidrug therapy with cofactor

ADVENTRX announces positive data from multidrug therapy with cofactor

Martek's DHA algal oil reduces brain lesions in Alzheimer's animal model

Martek's DHA algal oil reduces brain lesions in Alzheimer's animal model

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

Schering-Plough selects Pharmacopeia compund for development

Schering-Plough selects Pharmacopeia compund for development

Lexicon Reports on anti-angiogenesis target discoveries

Lexicon Reports on anti-angiogenesis target discoveries

Scientists tackle cancer with different approaches

Scientists tackle cancer with different approaches

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Avalon Pharmaceuticals announces results of  AVN944 biomarker study

Avalon Pharmaceuticals announces results of AVN944 biomarker study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.